Literature DB >> 18317453

The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.

E M Bahassi1, J L Ovesen, A L Riesenberg, W Z Bernstein, P E Hasty, P J Stambrook.   

Abstract

The cellular response to the introduction of double strand DNA breaks involves complexes of protein interactions that govern cell cycle checkpoint arrest and repair of the DNA lesions. The checkpoint kinases Chk1 and Chk2 phosphorylate the carboxy-terminal domain of hBRCA2, a protein involved in recombination-mediated DNA repair (HRR) and replication fork maintenance. Cells deficient in hBRCA2 are hypersensitive to DNA damaging agents. Phosphorylation of the residue in hBRCA2 targeted by the Chk1 and Chk2 kinases regulates its interaction with Rad51. Furthermore, the cell line lex1/lex2, which lacks the carboxy-terminal domain containing the phosphorylated residue, does not support localization of Rad51 to nuclear foci after exposure to UV or treatment with ionizing radiation (IR). The data show that either phosphorylation of Rad51 by Chk1 or phosphorylation of the carboxy-terminal domain of hBRCA2 by Chk1 or Chk2 plays a critical role in the binding of Rad51 to hBRCA2 and the subsequent recruitment of Rad51 to sites of DNA damage. While depletion of Chk1 from cells leads to loss of Rad51 localization to nuclear foci in response to replication arrest, cells lacking Chk2 also show a defect in Rad51 localization, but only in presence of double strand DNA breaks, indicating that each of these kinases may contribute somewhat differently to the formation of Rad51 nucleoprotein filaments depending on the type of DNA damage incurred by the cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317453     DOI: 10.1038/onc.2008.17

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation.

Authors:  Ann Christin Parplys; Jasna Irena Seelbach; Saskia Becker; Matthias Behr; Agnieszka Wrona; Camilla Jend; Wael Yassin Mansour; Simon Andreas Joosse; Horst-Werner Stuerzbecher; Helmut Pospiech; Cordula Petersen; Ekkehard Dikomey; Kerstin Borgmann
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Replicating damaged DNA in eukaryotes.

Authors:  Nimrat Chatterjee; Wolfram Siede
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

3.  Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe.

Authors:  Nicholas J H Warren; Alan Eastman
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

4.  Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2008-10-06       Impact factor: 4.534

5.  LAMMER kinase contributes to genome stability in Ustilago maydis.

Authors:  Carmen de Sena-Tomás; Jeanette H Sutherland; Mira Milisavljevic; Dragana B Nikolic; José Pérez-Martín; Milorad Kojic; William K Holloman
Journal:  DNA Repair (Amst)       Date:  2015-06-19

6.  NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells.

Authors:  D Kraft; M Rall; M Volcic; E Metzler; A Groo; A Stahl; L Bauer; E Nasonova; D Salles; G Taucher-Scholz; H Bönig; C Fournier; L Wiesmüller
Journal:  Leukemia       Date:  2015-02-05       Impact factor: 11.528

7.  The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition.

Authors:  Kalindi Parmar; Bose S Kochupurakkal; Jean-Bernard Lazaro; Zhigang C Wang; Sangeetha Palakurthi; Paul T Kirschmeier; Chunyu Yang; Larissa A Sambel; Anniina Färkkilä; Elizaveta Reznichenko; Hunter D Reavis; Connor E Dunn; Lee Zou; Khanh T Do; Panagiotis A Konstantinopoulos; Ursula A Matulonis; Joyce F Liu; Alan D D'Andrea; Geoffrey I Shapiro
Journal:  Clin Cancer Res       Date:  2019-08-13       Impact factor: 12.531

8.  mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.

Authors:  Andrew J Massey; Peter Stephens; Rebecca Rawlinson; Lauren McGurk; Ruth Plummer; Nicola J Curtin
Journal:  Mol Oncol       Date:  2015-08-25       Impact factor: 6.603

9.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  The intersection between DNA damage response and cell death pathways.

Authors:  S Nowsheen; E S Yang
Journal:  Exp Oncol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.